These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35312162)

  • 1. BRCA1/2 testing among young women with breast cancer in Massachusetts, 2010-2013: An observational study using state cancer registry and All-Payer claims data.
    Pace LE; Ayanian JZ; Wolf RE; Knowlton R; Gershman ST; Hawkins SS; Keating NL
    Cancer Med; 2022 Jul; 11(13):2679-2686. PubMed ID: 35312162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRCA1/2 Testing in Massachusetts Among Women With Private Insurance or Medicaid, 2011-2015.
    Pace LE; Baum CF; Horvath K; Raja SC; Cohen J; Hawkins SS
    Med Care; 2020 Nov; 58(11):963-967. PubMed ID: 32925457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment Disparities in Radiation and Hormone Therapy Among Women Covered by Medicaid vs Private Insurance in Cancer Registry and Claims Data.
    Bradley CJ; Sabik LM; Liang R; Lindrooth RC; Perraillon MC
    JAMA Health Forum; 2023 May; 4(5):e230673. PubMed ID: 37145688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast Cancer.
    McCarthy AM; Bristol M; Domchek SM; Groeneveld PW; Kim Y; Motanya UN; Shea JA; Armstrong K
    J Clin Oncol; 2016 Aug; 34(22):2610-8. PubMed ID: 27161971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high frequency of BRCA mutations in young black women with breast cancer residing in Florida.
    Pal T; Bonner D; Cragun D; Monteiro AN; Phelan C; Servais L; Kim J; Narod SA; Akbari MR; Vadaparampil ST
    Cancer; 2015 Dec; 121(23):4173-80. PubMed ID: 26287763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial differences in the treatment and outcomes for prostate cancer in Massachusetts.
    Cole AP; Herzog P; Iyer HS; Marchese M; Mahal BA; Lipsitz SR; Nyambose J; Gershman ST; Kennedy M; Merriam G; Rebbeck TR; Trinh QD
    Cancer; 2021 Aug; 127(15):2714-2723. PubMed ID: 33999405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial and ethnic disparities among state Medicaid programs for breast cancer screening.
    Tangka FK; Subramanian S; Mobley LR; Hoover S; Wang J; Hall IJ; Singh SD
    Prev Med; 2017 Sep; 102():59-64. PubMed ID: 28647544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Insurance Status and Racial Disparities With the Detection of Early-Stage Breast Cancer.
    Ko NY; Hong S; Winn RA; Calip GS
    JAMA Oncol; 2020 Mar; 6(3):385-392. PubMed ID: 31917398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk.
    Levy DE; Byfield SD; Comstock CB; Garber JE; Syngal S; Crown WH; Shields AE
    Genet Med; 2011 Apr; 13(4):349-55. PubMed ID: 21358336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial and socio-economic disparities in breast cancer hospitalization outcomes by insurance status.
    Akinyemiju T; Sakhuja S; Vin-Raviv N
    Cancer Epidemiol; 2016 Aug; 43():63-9. PubMed ID: 27394678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing participants in the North Carolina Breast and Cervical Cancer Control Program: A retrospective review of 90,000 women.
    Tait SD; Ren Y; Horton CC; Oshima SM; Thomas SM; Wright S; Caesar A; Plichta JK; Hwang ES; Greenup RA; Rosenberger LH; DiLalla GD; Menendez CS; Tolnitch L; Hyslop T; Nelson D; Fayanju OM
    Cancer; 2021 Jul; 127(14):2515-2524. PubMed ID: 33826758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer.
    Kurian AW; Ward KC; Hamilton AS; Deapen DM; Abrahamse P; Bondarenko I; Li Y; Hawley ST; Morrow M; Jagsi R; Katz SJ
    JAMA Oncol; 2018 Aug; 4(8):1066-1072. PubMed ID: 29801090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ.
    Liu Y; Ide Y; Inuzuka M; Tazawa S; Kanada Y; Matsunaga Y; Kuwayama T; Sawada T; Akashi-Tanaka S; Nakamura S
    Mol Genet Genomic Med; 2019 Mar; 7(3):e493. PubMed ID: 30652428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic testing in privately insured women with surgically treated breast cancer.
    Dinan MA; Pitafi S; Greenup RA; Long JB; Gross CP
    Breast Cancer Res Treat; 2023 Feb; 198(1):177-181. PubMed ID: 36542252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial and Ethnic Disparities in Oncotype DX Test Receipt in a Statewide Population-Based Study.
    Davis BA; Aminawung JA; Abu-Khalaf MM; Evans SB; Su K; Mehta R; Wang SY; Gross CP
    J Natl Compr Canc Netw; 2017 Mar; 15(3):346-354. PubMed ID: 28275035
    [No Abstract]   [Full Text] [Related]  

  • 16. The Role of Socioeconomic Status and Health Care Access in Breast Cancer Screening Compliance Among Hispanics.
    Jadav S; Rajan SS; Abughosh S; Sansgiry SS
    J Public Health Manag Pract; 2015; 21(5):467-76. PubMed ID: 25756197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis.
    Halpern MT; Ward EM; Pavluck AL; Schrag NM; Bian J; Chen AY
    Lancet Oncol; 2008 Mar; 9(3):222-31. PubMed ID: 18282806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study.
    Narod SA; Lubinski J; Ghadirian P; Lynch HT; Moller P; Foulkes WD; Rosen B; Kim-Sing C; Isaacs C; Domchek S; Sun P;
    Lancet Oncol; 2006 May; 7(5):402-6. PubMed ID: 16648044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between health insurance status, neighborhood deprivation, and treatment delays in women with breast cancer living in Georgia.
    Awan S; Saini G; Gogineni K; Luningham JM; Collin LJ; Bhattarai S; Aneja R; Williams CP
    Cancer Med; 2023 Aug; 12(16):17331-17339. PubMed ID: 37439033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are physician recommendations for BRCA1/2 testing in patients with breast cancer appropriate? A population-based study.
    McCarthy AM; Bristol M; Fredricks T; Wilkins L; Roelfsema I; Liao K; Shea JA; Groeneveld P; Domchek SM; Armstrong K
    Cancer; 2013 Oct; 119(20):3596-603. PubMed ID: 23861169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.